Clinical Trial

Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization

Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-03; most recent amendment 2026-04-09.
Trial Details
NCT Number NCT07224906
Lead Sponsor HemoCept Inc.
Conditions Pulmonary Hypertension, Congestive Heart Failure(CHF), Valve Disease, Heart
Enrollment 50 participants
Start Date 2025-12-01
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-13